Efficacy and safety of neoadjuvant camrelizumab and apatinib combined with chemotherapy in stage IIIA (N2) NSCLC: a multi-center, single-arm, phase II trial
新辅助卡瑞利珠单抗和阿帕替尼联合化疗治疗IIIA期(N2)非小细胞肺癌的疗效和安全性:一项多中心、单臂II期试验
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04416-0
Zhao, Lilan; Guo, Tianxing; Zhang, Yi; Huang, Zhen; Huang, Yangyun; Zhu, Lihuan; Chen, Xing; Zhang, Nan; Guo, Liren; Huang, Rongzhi; Geng, Guojun; Li, Ning; Chen, Shuxing; Pan, Xiaojie; Chen, Wenshu